146 related articles for article (PubMed ID: 14606076)
1. Effects of splenectomy in patients with cirrhosis undergoing hepatic resection for hepatocellular carcinoma.
Cao ZX; Chen XP; Wu ZD
World J Gastroenterol; 2003 Nov; 9(11):2460-3. PubMed ID: 14606076
[TBL] [Abstract][Full Text] [Related]
2. Changes of immune function in patients with liver cirrhosis after splenectomy combined with resection of hepatocellular carcinoma.
Cao ZX; Chen XP; Wu ZD
Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):562-5. PubMed ID: 14627520
[TBL] [Abstract][Full Text] [Related]
3. [Changes of immune function in liver cirrhosis patients after splenectomy combined with resection of hepatocellular carcinoma].
Cao Z; Cheng X; Wu Z
Zhonghua Wai Ke Za Zhi; 2002 Feb; 40(2):97-9. PubMed ID: 11955389
[TBL] [Abstract][Full Text] [Related]
4. [Role of united hepatectomy and splenectomy in the surgical treatment of hepatocellular carcinoma complicated with hepatic cirrhosis and hypersplenism].
Chen XP; Wu ZD; Qiu FZ
Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):442-6. PubMed ID: 15854370
[TBL] [Abstract][Full Text] [Related]
5. Concomitant splenectomy for hypersplenic thrombocytopenia in hepatic resection for hepatocellular carcinoma.
Lin MC; Wu CC; Ho WL; Yeh DC; Liu TJ; P'eng FK
Hepatogastroenterology; 1999; 46(26):630-4. PubMed ID: 10370587
[TBL] [Abstract][Full Text] [Related]
6. [Long-term effect of united hepatectomy and splenectomy on treatment of hepatocellular carcinoma complicated with cirrhosis and hypersplenism].
Cai JQ; Hu JQ; Bi XY; Zhao JJ; Che X; Xie SL; Shao YF; Zhao P
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):6-8. PubMed ID: 14990147
[TBL] [Abstract][Full Text] [Related]
7. Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism.
Chen XP; Wu ZD; Huang ZY; Qiu FZ
Br J Surg; 2005 Mar; 92(3):334-9. PubMed ID: 15672441
[TBL] [Abstract][Full Text] [Related]
8. Appraisal of simultaneous laparoscopic splenectomy and hepatic resection in the treatment of hepatocellular carcinoma with hypersplenic thrombocytopenia.
Miyoshi A; Ide T; Kitahara K; Noshiro H
Hepatogastroenterology; 2013 Oct; 60(127):1689-92. PubMed ID: 23933787
[TBL] [Abstract][Full Text] [Related]
9. The long-term effects of splenectomy and subsequent interferon therapy in patients with HCV-related liver cirrhosis.
Inagaki Y; Sugimoto K; Shiraki K; Tameda M; Kusagawa S; Nojiri K; Ogura S; Yamamoto N; Takei Y; Ito M; Mizuno S; Usui M; Sakurai H; Isaji S
Mol Med Rep; 2014 Feb; 9(2):487-92. PubMed ID: 24336960
[TBL] [Abstract][Full Text] [Related]
10. Appraisal of concomitant splenectomy in liver resection for hepatocellular carcinoma in cirrhotic patients with hypersplenic thrombocytopenia.
Wu CC; Cheng SB; Ho WM; Chen JT; Yeh DC; Liu TJ; P'eng FK
Surgery; 2004 Sep; 136(3):660-8. PubMed ID: 15349116
[TBL] [Abstract][Full Text] [Related]
11. Synchronous splenectomy and hepatectomy in patients with hepatocellular carcinoma, hypersplenism and liver cirrhosis.
Shi R; Zhang YM; Zhu ZJ; Deng YL; Pan C; Zheng H; Shen ZY
Hepatogastroenterology; 2014; 61(133):1363-7. PubMed ID: 25436312
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment for hepatocellular carcinoma and secondary hypersplenism.
Wang Q; Sun K; Li XH; Peng BG; Liang LJ
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):396-400. PubMed ID: 16911938
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of splenectomy in advanced cirrhotic patients with hepatocellular carcinoma and thrombocytopenia.
Ogata T; Okuda K; Sato T; Hirakawa Y; Yasunaga M; Horiuchi H; Nomura Y; Kage M; Ide T; Kuromatsu R; Kinoshita H; Tanaka H
Kurume Med J; 2013; 60(2):37-45. PubMed ID: 24064764
[TBL] [Abstract][Full Text] [Related]
14. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
Giannini EG; Savarino V; Farinati F; Ciccarese F; Rapaccini G; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Liver Int; 2013 Nov; 33(10):1594-600. PubMed ID: 23654354
[TBL] [Abstract][Full Text] [Related]
15. Safety of synchronous hepatectomy and splenectomy for patients with hepatocellular carcinoma and hypersplenism.
Wang C; Li C; Wen TF; Yan LN; Li B; Liang GL; Li KW
Hepatogastroenterology; 2012; 59(114):526-8. PubMed ID: 22353518
[TBL] [Abstract][Full Text] [Related]
16. The role of splenectomy in patients with hepatocellular carcinoma and secondary hypersplenism.
Oh JW; Ahn SM; Kim KS; Choi JS; Lee WJ; Kim BR
Yonsei Med J; 2003 Dec; 44(6):1053-8. PubMed ID: 14703616
[TBL] [Abstract][Full Text] [Related]
17. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
18. [Peri-operative treatment for hepatocellular carcinoma patients complied with cirrhosis and hypersplenism].
Bi XY; Zhao JJ; Yan T; Li C; Zhou HT; Huang Z; Zhao H; Cai JQ
Zhonghua Wai Ke Za Zhi; 2010 Oct; 48(20):1539-41. PubMed ID: 21176666
[TBL] [Abstract][Full Text] [Related]
19. Splenic arterial ligation prevents liver injury after a major hepatectomy by a reduction of surplus portal hypertension in hepatocellular carcinoma patients with cirrhosis.
Sato Y; Kobayashi T; Nakatsuka H; Yamamoto S; Oya H; Watanabe T; Hatakeyama K
Hepatogastroenterology; 2001; 48(39):831-5. PubMed ID: 11462934
[TBL] [Abstract][Full Text] [Related]
20. Splenectomy before hepatectomy for patients with hepatocellular carcinoma and hypersplenism: A retrospective study.
Zhou C; Huang Y; Shu C; Zhou J; Hu X; Wang J; Wang Y; Zhang Z; Chen L; Chen X; Zhang Z
Medicine (Baltimore); 2021 Jan; 100(4):e24326. PubMed ID: 33530224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
